Protein Shows Promise for Anticoagulation in Chronic Kidney DiseaseA protein called STUB1 may help prevent blood clots in patients with chronic kidney disease without causing bleeding complications.
Pharmacists Must Weigh DOACs’ Benefits Versus RisksDirect oral anticoagulants have expanded treatment options for patients with venous thromboembolisms, but they are not for everyone.
Warfarin Linked to Lower Cancer RiskA large Norwegian cohort study has found that warfarin is associated with a reduced risk of cancer.
DOACs Used in Dialysis Patients, but Little Research Has Been DoneDialysis patients are often treated with direct oral anticoagulants, despite little research in this population.
New Resource Educates about Therapies for DVTA new resource for patients with deep vein thrombosis aims to educate about interventional therapies.
Anticoagulants Linked to Lower Dementia RiskOral anticoagulants are associated with a significant reduction in dementia risk for atrial fibrillation patients.
Newer Anticoagulants May Reduce Intraocular BleedingThe risk of intraocular bleeding was reduced by one-fifth when using newer anticoagulants versus warfarin in a new study.
Using NOACs Reduces Bleeding RisksDual antithrombotic therapy using dabigatran significantly reduces risk of bleeding compared to triple therapy using warfarin.
Rivaroxaban Shown to Cut Risk of Cardiovascular EventsRivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.
Patient and Physician Education Boosts Anticoagulant Adherence RatesEducation about anticoagulants helped boost adherence rates and led to a small decrease in stroke risk.